Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Mar;69(3):445–451. doi: 10.1038/bjc.1994.81

Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. United Kingdom Children's Cancer Study Group.

C P Taylor 1, A G McGuckin 1, N P Bown 1, M M Reid 1, A J Malcolm 1, A D Pearson 1, D Sheer 1
PMCID: PMC1968838  PMID: 8123471

Abstract

A number of biological factors have been identified which correlate with prognosis in neuroblastoma. Among these are genetic aberrations, including ploidy, deletions of chromosome 1p and N-myc amplification. Conventional methods of detecting these changes, such as tissue culture for karyotyping and Southern blotting, are time-consuming and yield interpretable results in only a small proportion of cases. We have developed interphase fluorescence in situ hybridisation for use on tumour imprints and bone marrow smears, allowing rapid visualisation of the relevant genetic changes. Valuable prognostic information is therefore available in a few days: the results in our cases were later confirmed by conventional methods. In the foreseeable future it will be possible to define distinct prognostic categories on the basis both of this genetic information and other parameters, and separate therapeutic strategies may then be employed for the different patient groups.

Full text

PDF
445

Images in this article

448Figure 1
on p.448
448Figure 2
on p.448
448Figure 3
on p.448
448Figure 4
on p.448
448Figure 5
on p.448
448Figure 6
on p.448
449Figure 7
on p.449
449Figure 8
on p.449
449Figure 9
on p.449
449Figure 10
on p.449
449Figure 11
on p.449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourhis J., De Vathaire F., Wilson G. D., Hartmann O., Terrier-Lacombe M. J., Boccon-Gibod L., McNally N. J., Lemerle J., Riou G., Bénard J. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res. 1991 Jan 1;51(1):33–36. [PubMed] [Google Scholar]
  2. Brodeur G. M., Fong C. T. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 1989 Sep;41(2):153–174. doi: 10.1016/0165-4608(89)90243-4. [DOI] [PubMed] [Google Scholar]
  3. Brodeur G. M., Pritchard J., Berthold F., Carlsen N. L., Castel V., Castelberry R. P., De Bernardi B., Evans A. E., Favrot M., Hedborg F. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993 Aug;11(8):1466–1477. doi: 10.1200/JCO.1993.11.8.1466. [DOI] [PubMed] [Google Scholar]
  4. Brodeur G. M., Seeger R. C., Barrett A., Berthold F., Castleberry R. P., D'Angio G., De Bernardi B., Evans A. E., Favrot M., Freeman A. I. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988 Dec;6(12):1874–1881. doi: 10.1200/JCO.1988.6.12.1874. [DOI] [PubMed] [Google Scholar]
  5. Brodeur G. M. TRK-a expression in neuroblastomas: a new prognostic marker with biological and clinical significance. J Natl Cancer Inst. 1993 Mar 3;85(5):344–345. doi: 10.1093/jnci/85.5.344. [DOI] [PubMed] [Google Scholar]
  6. Christiansen H., Lampert F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer. 1988 Jan;57(1):121–126. doi: 10.1038/bjc.1988.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Christiansen H., Schestag J., Christiansen N. M., Grzeschik K. H., Lampert F. Clinical impact of chromosome 1 aberrations in neuroblastoma: a metaphase and interphase cytogenetic study. Genes Chromosomes Cancer. 1992 Sep;5(2):141–149. doi: 10.1002/gcc.2870050208. [DOI] [PubMed] [Google Scholar]
  8. Cooke H. J., Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res. 1979 Jul 25;6(10):3177–3197. doi: 10.1093/nar/6.10.3177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Donner L. R. Cytogenetics and molecular biology of small round-cell tumors and related neoplasms. Current status. Cancer Genet Cytogenet. 1991 Jul 1;54(1):1–10. doi: 10.1016/0165-4608(91)90023-n. [DOI] [PubMed] [Google Scholar]
  10. Evans A. E., D'Angio G. J., Propert K., Anderson J., Hann H. W. Prognostic factor in neuroblastoma. Cancer. 1987 Jun 1;59(11):1853–1859. doi: 10.1002/1097-0142(19870601)59:11<1853::aid-cncr2820591102>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  11. Hayashi Y., Kanda N., Inaba T., Hanada R., Nagahara N., Muchi H., Yamamoto K. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer. 1989 Jan 1;63(1):126–132. doi: 10.1002/1097-0142(19890101)63:1<126::aid-cncr2820630120>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  12. Hopman A. H., Poddighe P. J., Smeets A. W., Moesker O., Beck J. L., Vooijs G. P., Ramaekers F. C. Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol. 1989 Dec;135(6):1105–1117. [PMC free article] [PubMed] [Google Scholar]
  13. Hopman A. H., Ramaekers F. C., Raap A. K., Beck J. L., Devilee P., van der Ploeg M., Vooijs G. P. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988;89(4):307–316. doi: 10.1007/BF00500631. [DOI] [PubMed] [Google Scholar]
  14. Look A. T., Hayes F. A., Shuster J. J., Douglass E. C., Castleberry R. P., Bowman L. C., Smith E. I., Brodeur G. M. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991 Apr;9(4):581–591. doi: 10.1200/JCO.1991.9.4.581. [DOI] [PubMed] [Google Scholar]
  15. Oppedal B. R., Storm-Mathisen I., Lie S. O., Brandtzaeg P. Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer. 1988 Aug 15;62(4):772–780. doi: 10.1002/1097-0142(19880815)62:4<772::aid-cncr2820620422>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  16. Pinkel D., Straume T., Gray J. W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 1986 May;83(9):2934–2938. doi: 10.1073/pnas.83.9.2934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schwab M. Is there a neuroblastoma anti-oncogene? Prog Clin Biol Res. 1991;366:1–9. [PubMed] [Google Scholar]
  18. Schwab M., Varmus H. E., Bishop J. M., Grzeschik K. H., Naylor S. L., Sakaguchi A. Y., Brodeur G., Trent J. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature. 1984 Mar 15;308(5956):288–291. doi: 10.1038/308288a0. [DOI] [PubMed] [Google Scholar]
  19. Shimada H., Chatten J., Newton W. A., Jr, Sachs N., Hamoudi A. B., Chiba T., Marsden H. B., Misugi K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984 Aug;73(2):405–416. doi: 10.1093/jnci/73.2.405. [DOI] [PubMed] [Google Scholar]
  20. Silber J. H., Evans A. E., Fridman M. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology. Cancer Res. 1991 Mar 1;51(5):1426–1433. [PubMed] [Google Scholar]
  21. Stock C., Ambros I. M., Mann G., Gadner H., Amann G., Ambros P. F. Detection of Ip36 deletions in paraffin sections of neuroblastoma tissues. Genes Chromosomes Cancer. 1993 Jan;6(1):1–9. doi: 10.1002/gcc.2870060103. [DOI] [PubMed] [Google Scholar]
  22. Taylor C., Patel K., Jones T., Kiely F., De Stavola B. L., Sheer D. Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation. Br J Cancer. 1993 Jan;67(1):128–133. doi: 10.1038/bjc.1993.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Weith A., Martinsson T., Cziepluch C., Brüderlein S., Amler L. C., Berthold F., Schwab M. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer. 1989 Nov;1(2):159–166. doi: 10.1002/gcc.2870010209. [DOI] [PubMed] [Google Scholar]
  24. Woods W. G., Lemieux B., Tuchman M. Neuroblastoma represents distinct clinical-biologic entities: a review and perspective from the Quebec Neuroblastoma Screening Project. Pediatrics. 1992 Jan;89(1):114–118. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES